Medical Authorities Continue To Block Effective Covid Treatment
The conflict of interest between clinical trials of drugs that determine their effectiveness and safety and the pharmaceutical industry that funds most of the trials is astonishing. Yet nothing is done about it. Two-thirds of the Federal Food and Drug Administration’s budget for evaluating prescription drugs comes from the industry that the FDA regulates. In other words, the regulator is financed by the entity that it is supposed to regulate.
“Human Drugs regulatory activities account for 33 percent of FDA’s budget; 65 percent of these activities are paid for by industry user fees (Oct 18, 2019).”
It is this corrupt conflict of interest that has blocked the HCQ treatment of Covid-19. Hundreds of thousands of people have died and many others have been lef
Article from LewRockwell